Treating resistant hypertension with new devices

Minerva Cardioangiologica

Volumn 62, Issue 3, 2014, Pages 235-241

  Wienemann, H ^a   Meincke, F ^a   Kaiser, L ^a   Heeger, C H ^a   Bergmann, M W ^a  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

Author keywords

Denervation; Hypertension resistant to conventional therapy; Ultrasonography

Indexed keywords

CARDIOVASCULAR EQUIPMENT; CLINICAL TRIAL (TOPIC); HUMAN; KIDNEY DENERVATION; KIDNEY DENERVATION SYSTEM; META ANALYSIS (TOPIC); MULTI ELECTRODE NON IRRIGATED CATHETER ELECTRODE; MULTI ELECTRODE RENAL DENERVATION SYSTEM; RENAL DENERVATION CATHETER; RESISTANT HYPERTENSION; REVIEW; ADVERSE EFFECTS; BLOOD PRESSURE; COMPLICATION; DRUG COMBINATION; DRUG RESISTANCE; EQUIPMENT DESIGN; HYPERTENSION; INNERVATION; PATHOPHYSIOLOGY; PROCEDURES; RENAL ARTERY; SYMPATHECTOMY;

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; EQUIPMENT DESIGN; HUMANS; HYPERTENSION; RENAL ARTERY; SYMPATHECTOMY;

EID: 84904098910     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217-23. (Pubitemid 40138015)
2. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159-219.
3. Staessen JA, Wang J, Bianchi G, Birkenhager WH. Essential hypertension. Lancet 2003;361:1629-41. (Pubitemid 36579003)
4. de Jager RL, Blankestijn PJ. Pathophysiology I: the kidney and the sympathetic nervous system. EuroIntervention 2013;9 Suppl R: R42-7.
5. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13. (Pubitemid 35472129)
6. Holman RR, Paul SK, Bethel MA, Neil HA, Matthews DR. Long-term follow-up after tight control of blood pressure in type 2 diabetes. New Engl J Med 2008;359:1565-76.
7. Heeger CH, Kaiser L, Brooks S, Kuck KH, Bergmann MW. New Concepts for sympathetic renal artery denervation: Review of existing literature and case report. EMJ Int Cardiol 2013;1:34-42.
8. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. New Engl J Med 2006;354:2368-74.
9. Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, Ray CA; American College of Sports Medicine. American College of Sports Medicine position stand. Exercise and Hypertension. Med Sci Sports Exerc 2004;36:533-53.
10. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 2001;344:3-10. (Pubitemid 32064838)
11. Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2003;42:878-84. (Pubitemid 37413724)
12. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003;289:2363-9. (Pubitemid 37430168)
13. Fagard RH. Resistant hypertension. Heart 2012;98:254-61.
14. de la Sierra A, Segura J, Banegas JR, Gorostidi M, de la Cruz JJ, Armario P et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 2011;57:898-902.
15. Ott C, Schneider MP, Schmieder RE. Ruling out secondary causes of hypertension. EuroIntervention 2013;9 Suppl R: R21-8.
16. Polimeni A, Curcio A, Indolfi C. Renal sympathetic denervation for treating resistant hypertension. Circul J 2013;77:857-63.
17. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. New Engl J Med 2009;361:932-4.
18. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010;376:1903-9.
19. Symplicity HTNI. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 2011;57:911-7.
20. Esler MD, Krum H, Schlaich M, et al. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation 2012;126:2976-82.
21. Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O et al. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation 2013;128:132-40.
22. Kaiser L, Beister T, Wiese A, von Wedel J, Meincke F, Kreidel F et al. Results of the ALSTER BP real-world registry on renal denervation employing the Symplicity system. Eurointervention 2014 [Epub ahead of print].
23. Ahmed H, Miller MA, Dukkipati SR, Cammack S, Koruth JS, Gangireddy S et al. Adjunctive renal sympathetic denervation to modify hypertension as upstream therapy in the treatment of atrial fibrillation (H-FIB) study: clinical background and study design. J Cardiovasc Electrophysiol 2013;24:503-9.
24. Mahfoud F, Urban D, Teller D, Linz D, Stawowy P, Hassel JH et al. Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial. Eur Heart J 2014 [Epub ahead of print]
25. Lenski M, Mahfoud F, Razouk A, Ukena C, Lenski D, Barth C et al. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension. Int J Cardiol 2013;169:418-24.
26. Schlegel F, Daneschnejad SS, Mavlikeev M, Klein S, Vollroth M, Salameh A et al. Early effects in perivascular nerves and arterial media following renal artery denervation. Hypertension 2014;63:e123-5.
27. Esler M. Renal denervation for hypertension: observations and predictions of a founder. Eur Heart J 2014 [Epub ahead of print].
28. Kaltenbach B, Id D, Franke JC, Sievert H, Hennersdorf M, Maier J et al. Renal artery stenosis after renal sympathetic denervation. J Am Coll Cardiol 2012;60:2694-5.
29. Mahfoud F, Bohm M, Rump LC, Vonend O, Schmieder RE, Kintscher U. Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series. Hypertension 2013;61:e17.
30. Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE et al. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension Hypertension 2014;63:991-9.
31. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009;373:1275-81.
32. Krum H, Schlaich MP, Sobotka PA, Böhm M, Mahfoud F, Rocha-Singh K et al. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet 2014;383:622-9.
33. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT et al. A controlled trial of renal denervation for resistant hypertension. N N Engl J Med. 2014 Apr 10;370:1393-401.
34. Flack JM, Sica DA, Bakris G, Brown AL, Ferdinand KC, Grimm RH Jr et al. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension 2010;56:780-800.
35. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507-20.
36. Mahfoud F, Bhatt DL. Catheter-based renal denervation: the black box procedure. JACC Cardiovasc Interv 2013;6:1092-4.
37. Vonend O, Antoch G, Rump LC, Blondin D. Secondary rise in blood pressure after renal denervation. Lancet 2012;380:778.